Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 70849

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
March 26, 2015
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Actavis Laboratories, FL, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

D-0488-2015
Recall number
D-0488-2015
Initiated
March 26, 2015
Classification
Class III
Status
Terminated
Quantity
2,628 bottles

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
Foreign Substance

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

Code information

Lot # 956000M, Exp. Aug 2016; UPC 3-6203760090-6

Distribution pattern

Nationwide